From Our Affiliates

Tag: Genzyme

A total of 42 posts are filed under Genzyme
PDL BioPharma Buys Share of Cerdelga Royalties for $65.6M
Source. PDL BioPharma said yesterday it acquired a portion of the University of Michigan (U-M) worldwide royalty interest in Cerdelga™… Continue Reading
New RARE Toolkit “Searching For Answers: Contacting Biopharmaceutical Companies Effectively”
“I can do that?” This is the question patients ask when it comes to the possibility of working directly with biopharmaceutical… Continue Reading
Genzyme Providing $900K Towards Gene Therapy Research for Childhood Blindness
Genzyme is entering the fields of ophthalmology and gene therapy.  Today, the company announced they are providing $900,000 in funding to… Continue Reading
The Balancing Act®’s Behind The Mystery on Lifetime Talks Pompe Disease This Tuesday 6/3
Behind the Mystery of Pompe Disease It’s a devastating medical mystery: random symptoms that present in many common diseases; low… Continue Reading
Boston Marathon: Genzyme Runners Supporting ‘Rare’ Cause
By Anamika Roy Daily News Staff A team of Genzyme employees is running for a “rare” cause on Marathon Monday. In partnership with the… Continue Reading
“What Are Biomarkers?” a Webinar by the AMDA and Genzyme on April 15th
Learn about Biomarkers – what they are, why they are important, and what Genzyme is doing to understand Biomarkers in Pompe disease.… Continue Reading
Screen Shot 2014-04-07 at 9.36.09 AM
Voices Carry: How History Informs Patient Advocacy in the Biotech Industry
During this 90-minute discussion presented by the Life Sciences Foundation and MassBio, a panel of biotech leaders will discuss how patient… Continue Reading
1 2 3 6